We are live on
!
Find out more
IRAG
Investment Research & Advisory Group Portfolio holdings
AUM
$324M
1-Year Est. Return
22.57%
This Fund
S&P 500
This Quarter
Est. Return
+12.64%
1 Year Est. Return
+22.57%
3 Year Est. Return
+88.65%
5 Year Est. Return
+107.32%
10 Year Est. Return
–
AUM
$196M
AUM Growth
+$19.7M
(+11%)
Cap. Flow
-$1.02M
Cap. Flow
% of AUM
-0.52%
Top 10 Holdings %
Top 10 Hldgs %
53.85%
Holding
236
New
19
Increased
36
Reduced
35
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$1.57M |
| 2 |
Vanguard Total Bond Market
BND
|
+$1.24M |
| 3 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$151K |
| 4 |
Eli Lilly
LLY
|
+$98.1K |
| 5 |
GE Aerospace
GE
|
+$88K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$959K |
| 2 |
United Parcel Service
UPS
|
+$787K |
| 3 |
Veeva Systems
VEEV
|
+$712K |
| 4 |
Walt Disney
DIS
|
+$474K |
| 5 |
Becton Dickinson
BDX
|
+$371K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.92% |
| 2 | Financials | 15.4% |
| 3 | Healthcare | 8.85% |
| 4 | Communication Services | 7.48% |
| 5 | Consumer Discretionary | 6.67% |
Similar funds
FAL
AIA
AC
UOC
BCP
THCM
CRI
WG
Investment Research & Advisory Group's Q4 2023 Portfolio in Review
As of Q4 2023, Investment Research & Advisory Group held 236 positions worth $196M, up 11% from $176M the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Investment Research & Advisory Group's Q4 2023 filing shows 19 new, 36 increased, 35 reduced and 14 closed positions. Its largest new stake was State Street SPDR Portfolio S&P 600 Small Cap ETF: 330 shares worth $13.9K. The largest sale was Pfizer, an estimated $959K.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Investment Research & Advisory Group's largest Q4 2023 buy was State Street SPDR Portfolio S&P 600 Small Cap ETF: 330 shares worth $13.9K.
- Investment Research & Advisory Group added most to Vanguard S&P 500 ETF in Q4 2023, an estimated $1.57M increase.
- Investment Research & Advisory Group's biggest Q4 2023 reduction was Pfizer, cutting an estimated $959K.
- Investment Research & Advisory Group fully exited Advanced Micro Devices in Q4 2023, selling an estimated $91.5K.
- Investment Research & Advisory Group's ten largest holdings make up 54% of its $196M portfolio in Q4 2023.
- Investment Research & Advisory Group opened 19 new positions and closed 14 in Q4 2023.
- Investment Research & Advisory Group's portfolio value rose 11% quarter-over-quarter to $196M.
Based on Investment Research & Advisory Group's 13F filing for Q4 2023, filed 18 Jan 2024.